Found: 9
Select item for more details and to access through your institution.
PREVENT: A Randomized, Placebo-controlled Crossover Trial of Avexitide for Treatment of Postbariatric Hypoglycemia.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Critical role for GLP-1 in symptomatic post-bariatric hypoglycaemia.
- Published in:
- Diabetologia, 2017, v. 60, n. 3, p. 531, doi. 10.1007/s00125-016-4179-x
- By:
- Publication type:
- Article
Safety, efficacy and pharmacokinetics of repeat subcutaneous dosing of avexitide (exendin 9‐39) for treatment of post‐bariatric hypoglycaemia.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 8, p. 1406, doi. 10.1111/dom.14048
- By:
- Publication type:
- Article
Efficacy and pharmacokinetics of subcutaneous exendin (9‐39) in patients with post‐bariatric hypoglycaemia.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 352, doi. 10.1111/dom.13078
- By:
- Publication type:
- Article
Adipose tissue macrophages impair preadipocyte differentiation in humans.
- Published in:
- PLoS ONE, 2017, v. 12, n. 2, p. 1, doi. 10.1371/journal.pone.0170728
- By:
- Publication type:
- Article
Plasma FGF-19 Levels are Increased in Patients with Post-Bariatric Hypoglycemia.
- Published in:
- Obesity Surgery, 2019, v. 29, n. 7, p. 2092, doi. 10.1007/s11695-019-03845-0
- By:
- Publication type:
- Article
Pasireotide induced adrenal insufficiency.
- Published in:
- Clinical Endocrinology, 2016, v. 84, n. 6, p. 946, doi. 10.1111/cen.13016
- By:
- Publication type:
- Article
79-LB: Pharmacokinetics and Pharmacodynamics of Avexitide (Exendin 9-39) in Neonates and Infants with Congenital Hyperinsulinism.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-79-LB
- By:
- Publication type:
- Article
Adipose Cell Size and Regional Fat Deposition as Predictors of Metabolic Response to Overfeeding in Insulin-Resistant and Insulin-Sensitive Humans.
- Published in:
- 2016
- By:
- Publication type:
- journal article